Exencial Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $694K | Sell |
1,560
-76
| -5% | -$33.8K | 0.02% | 333 |
|
|
2025
Q1 | $793K | Sell |
1,636
-72
| -4% | -$34.9K | 0.03% | 309 |
|
|
2024
Q4 | $688K | Sell |
1,708
-13
| -0.8% | -$5.23K | 0.03% | 325 |
|
|
2024
Q3 | $801K | Sell |
1,721
-713
| -29% | -$332K | 0.03% | 296 |
|
|
2024
Q2 | $1.14M | Sell |
2,434
-89
| -4% | -$41.7K | 0.04% | 256 |
|
|
2024
Q1 | $1.05M | Sell |
2,523
-219
| -8% | -$91.5K | 0.04% | 267 |
|
|
2023
Q4 | $1.12M | Sell |
2,742
-551
| -17% | -$224K | 0.05% | 249 |
|
|
2023
Q3 | $1.15M | Sell |
3,293
-385
| -10% | -$134K | 0.06% | 222 |
|
|
2023
Q2 | $1.29M | Sell |
3,678
-669
| -15% | -$235K | 0.06% | 216 |
|
|
2023
Q1 | $1.37M | Sell |
4,347
-678
| -13% | -$214K | 0.07% | 198 |
|
|
2022
Q4 | $1.45M | Sell |
5,025
-29,875
| -86% | -$8.63M | 0.08% | 192 |
|
|
2022
Q3 | $10.1M | Sell |
34,900
-1,176
| -3% | -$341K | 0.61% | 47 |
|
|
2022
Q2 | $10.2M | Sell |
36,076
-2,824
| -7% | -$796K | 0.57% | 52 |
|
|
2022
Q1 | $10.2M | Buy |
38,900
+1,083
| +3% | +$283K | 0.51% | 62 |
|
|
2021
Q4 | $8.31M | Buy |
37,817
+1,213
| +3% | +$266K | 0.4% | 87 |
|
|
2021
Q3 | $6.64M | Buy |
36,604
+14,923
| +69% | +$2.71M | 0.29% | 92 |
|
|
2021
Q2 | $4.37M | Buy |
21,681
+2,768
| +15% | +$558K | 0.24% | 125 |
|
|
2021
Q1 | $4.06M | Buy |
18,913
+5,001
| +36% | +$1.07M | 0.24% | 127 |
|
|
2020
Q4 | $3.29M | Buy |
+13,912
| New | +$3.29M | 0.22% | 127 |
|
|
2020
Q3 | – | Sell |
-692
| Closed | -$201K | – | 361 |
|
|
2020
Q2 | $201K | Buy |
+692
| New | +$201K | 0.02% | 313 |
|